MedPath

Dutasteride

These highlights do not include all the information needed to use DUTASTERIDE CAPSULES safely and effectively. See full prescribing information for DUTASTERIDE CAPSULES. DUTASTERIDE capsules, for oral use Initial U.S. Approval: 2001

Approved
Approval ID

d4c90e01-1c61-6865-e053-2995a90ae6dd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 4, 2022

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dutasteride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68071-2610
Application NumberANDA206574
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dutasteride
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 4, 2022
FDA Product Classification

INGREDIENTS (10)

FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171K
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
CAPRYLIC/CAPRIC MONO/DIGLYCERIDESInactive
Code: U72Q2I8C85
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
DUTASTERIDEActive
Quantity: 0.5 mg in 1 1
Code: O0J6XJN02I
Classification: ACTIB
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dutasteride - FDA Drug Approval Details